Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The Takeaway While both Novo and Lilly have multi-year regulatory head-starts and are now rapidly becoming part of the zeitgeist around treating obesity, Regenerons angle of addressing muscle loss could help set it apart from other GLP-1 hopefuls and even incumbents by leading to improved long-term outcomes.
Suppressed glucagon: GLP-1 reduces the release of glucagon, a hormone that signals the liver to release stored glucose
You can find the FDA Category 2 Bulk Drug Substances list here
Explore our full range of Critical Care Injectables
US$ 22.58
US$ 24.30
US$ 27.07
US$ 23.69
US$ 25.35
US$ 29.91
US$ 26.44
US$ 26.48
US$ 22.06
US$ 20.56
US$ 25.75
US$ 26.69
US$ 27.04
US$ 22.65
